Shear stress, SIRT1, and Arterial Stiffening

剪切应力、SIRT1 和动脉硬化

基本信息

  • 批准号:
    8145200
  • 负责人:
  • 金额:
    $ 38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-20 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Arterial stiffening, manifested by thickening and reduced elasticity of conduit arteries, is an independent risk factor for stroke and heart disease. Although the etiology of arterial stiffening correlates well with aging, the underlying cellular and molecular basis remains unclear. In vivo, hemodynamic forces dynamically act on the vascular wall, which greatly affect arterial function and mechanical properties. Arterial stiffening may involves aberrant endothelial response to shear stress resulted from these hemodynamic forces. We recently found that SIRT1, an anti-aging regulator is modulated by shear stress in vascular endothelial cells (ECs). Moreover, calmodulin-dependent protein kinase (CaMKK) appears to be a shear stress-sensitive kinase that regulates SIRT1. We thus hypothesize that shear stress upregulates SIRT1 in the endothelium of conduit arteries, which ameliorates pathophysiological remodeling leading to arterial stiffening. At the upstream, CaMKKb is activated in response to the physiologically relevant shear stress. As a consequence of the activated CaMKKb-SIRT1 pathway, the endothelial nitric oxide synthase (eNOS)-derived NO bioavailability and PGC-1a-regulated ROS scavenger expression are augmented. Thus, the advantageous effects of shear stress-augmented SIRT1 include decreased oxidative stress and remodeling of extracellular matrices. To test our hypothesis, three Specific Aims are proposed. Specific Aim 1 will examine the hemodynamic factors critical for the induction of SIRT1 in cultured ECs. Molecular signaling experiments will then be conducted to study the mechanism by which CaMKKb regulates SIRT1 in ECs responding to the defined shear stress. Specific Aim 2 will elucidate the cellular and molecular mechanisms by which shear stress-induced SIRT1 exerts anti- stiffening effects in an EC/vascular smooth muscle cell co-culture system. We will decipher the synergistic effect of SIRT1 and AMP-activated protein kinase (AMPK) in eNOS-derived NO bioavailability and PGC-1a-regulated reactive oxygen species (ROS) scavengers. Specific Aim 3 will investigate the role of shear stress-activated SIRT1 in arterial stiffening in mouse models. Specifically, we will compare the spatiotemporal changes of arterial stiffening in EC-sirt1-/- knockout, Tg-EC-sirt1, and CaMKKb-/- mice. The arterial stiffening-associated changes in hemodynamic factors, aortic wall remodeling, and gene expression profiles will be measured and correlated. Results from these proposed studies, if as anticipated, will help to understand the mechano and molecular basis of arterial stiffening. PUBLIC HEALTH RELEVANCE: Arterial stiffening, associated with the aging process, is an independent risk factor for many cardiovascular diseases. SIRT1 is a master regulator involved in many anti-stress responses and we recently found that hemodynamic force can activate SIRT1 in vascular cells. This proposed study will investigate the mechano and molecular basis of flow induction of SIRT1, which would be anti-arterial stiffening. The proposal will significantly increase our understanding of mechanisms by which blood flow interplays with aging process in arterial stiffening. Results from the proposed experiments are likely to contribute to novel therapies for its prevention and/or treatment.
描述(申请人提供):动脉硬化,表现为导管动脉的增厚和弹性降低,是中风和心脏病的独立危险因素。尽管动脉硬化的病因与衰老有很好的相关性,但其潜在的细胞和分子基础仍不清楚。在体内,血流动力动态地作用于血管壁,极大地影响动脉的功能和力学特性。动脉硬化可能涉及血管内皮细胞对这些血流动力产生的剪切力的异常反应。我们最近发现,抗衰老调节因子SIRT1受血管内皮细胞(ECs)内切应力的调节。此外,钙调蛋白依赖的蛋白激酶(CaMKK)似乎是一种剪应力敏感的激酶,调节SIRT1。因此,我们假设切应力上调导管动脉内皮细胞中的SIRT1,从而改善导致动脉硬化的病理生理重塑。在上游,CaMKKb被激活,以响应生理上相关的剪应力。作为激活CaMKKb-SIRT1通路的结果,内皮型一氧化氮合酶(ENOS)衍生的NO生物利用度和PGC-1a调节的ROS清除剂的表达增强。因此,剪切力增强的SIRT1的有利作用包括减少氧化应激和细胞外基质的重塑。为了验证我们的假设,我们提出了三个具体目标。具体目标1将检测在培养的内皮细胞中诱导SIRT1的关键血流动力学因素。然后将进行分子信号实验,以研究CaMKKb调节内皮细胞SIRT1响应定义的剪应力的机制。具体目标2将阐明剪切力诱导的SIRT1在EC/血管平滑肌细胞共培养系统中发挥抗僵化作用的细胞和分子机制。我们将破译SIRT1和AMP激活的蛋白激酶(AMPK)在eNOS来源的NO生物利用度和PGC-1a调节的活性氧(ROS)清除剂中的协同作用。具体目标3将研究剪切力激活的SIRT1在小鼠模型动脉硬化中的作用。具体地说,我们将比较EC-SIRT1-/-基因敲除、TG-EC-SIRT1和CaMKKb-/-小鼠动脉硬化的时空变化。血液动力学因素、主动脉壁重构和基因表达谱中与动脉硬化相关的变化将被测量和关联。这些拟议研究的结果,如果如预期的那样,将有助于理解动脉硬化的机制和分子基础。 公共卫生相关性:动脉硬化与衰老过程相关,是许多心血管疾病的独立危险因素。SIRT1是参与许多抗应激反应的主要调节因子,我们最近发现血流动力学可以激活血管细胞中的SIRT1。这项研究将探讨SIRT1诱导血流的机制和分子基础,即抗动脉硬化。这一提议将显著增加我们对动脉硬化中血流与衰老过程相互作用的机制的理解。拟议的实验结果可能有助于预防和/或治疗该病的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John YJ Shyy其他文献

John YJ Shyy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John YJ Shyy', 18)}}的其他基金

AMPK Regulation of ACE2 in Endothelial Health and Disease
AMPK 在内皮健康和疾病中对 ACE2 的调节
  • 批准号:
    10568995
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
AMPK Regulation of ACE2 in Endothelial Health and Disease
AMPK 在内皮健康和疾病中对 ACE2 的调节
  • 批准号:
    10391055
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
MAE-WEST SCORE Project 3 Animal
MAE-WEST SCORE 项目 3 动物
  • 批准号:
    10198762
  • 财政年份:
    2020
  • 资助金额:
    $ 38万
  • 项目类别:
MAE-WEST SCORE Project 3 Animal
MAE-WEST SCORE 项目 3 动物
  • 批准号:
    10450764
  • 财政年份:
    2020
  • 资助金额:
    $ 38万
  • 项目类别:
MAE-WEST SCORE Project 3 Animal
MAE-WEST SCORE 项目 3 动物
  • 批准号:
    10696063
  • 财政年份:
    2020
  • 资助金额:
    $ 38万
  • 项目类别:
Flow-Induced Endothelial Innate Immunity and Atherosclerosis Susceptibility
血流诱导的内皮先天免疫和动脉粥样硬化易感性
  • 批准号:
    9751360
  • 财政年份:
    2016
  • 资助金额:
    $ 38万
  • 项目类别:
Flow-Induced Endothelial Innate Immunity and Atherosclerosis Susceptibility
血流诱导的内皮先天免疫和动脉粥样硬化易感性
  • 批准号:
    9185542
  • 财政年份:
    2016
  • 资助金额:
    $ 38万
  • 项目类别:
The miRNA-mediated Translational De-suppression in Hypoxic Endothelium
缺氧内皮细胞中 miRNA 介导的翻译去抑制
  • 批准号:
    8534808
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
The miRNA-mediated Translational De-suppression in Hypoxic Endothelium
缺氧内皮细胞中 miRNA 介导的翻译去抑制
  • 批准号:
    8716847
  • 财政年份:
    2012
  • 资助金额:
    $ 38万
  • 项目类别:
Shear stress, SIRT1, and Arterial Stiffening
剪切应力、SIRT1 和动脉硬化
  • 批准号:
    8282750
  • 财政年份:
    2010
  • 资助金额:
    $ 38万
  • 项目类别:

相似海外基金

Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 38万
  • 项目类别:
    Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
  • 批准号:
    BB/W009633/1
  • 财政年份:
    2022
  • 资助金额:
    $ 38万
  • 项目类别:
    Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 38万
  • 项目类别:
    Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
  • 批准号:
    459043
  • 财政年份:
    2021
  • 资助金额:
    $ 38万
  • 项目类别:
    Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 38万
  • 项目类别:
    Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10561642
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
    Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
  • 批准号:
    2243045
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
    Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10359032
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
  • 批准号:
    428988
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了